HQ Function

Serves as a key research and development hub and administrative center, historically driving global strategy and operations. Post-Novartis acquisition, its specific functions may evolve within the larger Novartis structure.

Notable Features:

Likely features state-of-the-art laboratory facilities tailored for antibody discovery and development, and modern office spaces fostering scientific collaboration. Specific architectural details are not widely publicized.

Work Culture:

Characterized by a strong emphasis on scientific innovation, rigorous research, collaboration across disciplines, and a patient-centric approach. The culture promotes a dynamic environment focused on advancing oncology treatments.

HQ Significance:

The Planegg site has been historically significant as the birthplace of MorphoSys's pioneering antibody technologies and the central hub for its growth into a notable biopharmaceutical player in oncology.

Values Reflected in HQ: The headquarters likely reflects MorphoSys's core values of innovation, scientific excellence, integrity, and a commitment to developing transformative therapies for cancer patients.

Location:

MorphoSys, now part of Novartis, has a global reach with key operations centered in Germany (R&D) and the United States (clinical development, commercial operations). Its therapies and development programs aim to impact cancer patients worldwide, leveraging Novartis's extensive global infrastructure and market access capabilities.

Street Address:

Semmelweisstrasse 7

City:

Planegg

State/Province:

Bavaria

Country:

Germany